The Pharmaceutical Industry in the Era of Artificial Intelligence

Category	Detail
Condition	AI in drug development
Key Mechanisms	The episode discusses AI’s role in the search for novel medicines and machine-learning technology at ModeX Therapeutics designed to create antibodies absent from nature. Zerhouni argues that human insight remains important to discovery.
Target Population	Podcast audience interested in AI and drug development
Care Setting	Pharmaceutical research and development; the episode also discusses the FDA and regulators overseas.

The episode examines AI’s role in drug development and whether it can generate discoveries as well as accelerate the search for medicines.
Elias Zerhouni describes machine-learning technology developed at ModeX Therapeutics to design antibodies absent from nature.
Zerhouni argues that human insight remains essential, using the discovery of the double helix as an example.
The discussion compares the FDA with regulators overseas and considers an AI slowdown alongside erosion of American research.

No specific patient population or prescribing data are provided.

The episode discusses AI in pharmaceutical research and development; it provides no treatment or prescribing recommendations.

Clinical Scorecard: The Drug Enterprise in the Age of AI